Healthcare’s AI governance gap is becoming a board-level risk
A new BDO analysis argues that healthcare already has AI in its workflows, but performance, compliance, and safety still depend on governance rather than model quality alone. The piece lands at a moment when providers are moving from experimentation to operational use, making oversight a competitive and regulatory issue, not just a policy topic.
Healthcare organizations have spent the last two years asking whether AI works. The more urgent question now is whether they have the governance to make it work consistently in real clinical and operational environments.
BDO’s framing is important because it reflects a broader industry shift: AI is no longer confined to pilots or innovation teams. It is being embedded in documentation, scheduling, revenue cycle, triage support, patient communications, and administrative decision-making, which means the risks are distributed across the enterprise rather than isolated in a single use case.
That creates a governance problem that looks a lot like a classic healthcare operations problem. If leaders cannot define who approves tools, how performance is monitored, when models are retrained, and what escalation path exists when output is wrong, then AI becomes a source of operational variability instead of efficiency. In healthcare, variability is not just a productivity issue; it can become a patient safety and compliance issue very quickly.
The article also highlights a strategic truth that many health systems are beginning to absorb: governance is not the enemy of innovation. It is what makes scale possible. Organizations that build repeatable review, audit, and accountability processes will be able to adopt AI faster than those that rely on one-off enthusiasm or ad hoc vendor promises.